(MedPage Today) — Use of proton pump inhibitors (PPIs) alongside anti-cancer agents was associated with worse survival outcomes in patients with breast cancer, according to an observational study.
Using pooled patient data from 19 breast cancer…
Source link : https://www.medpagetoday.com/hematologyoncology/breastcancer/118432
Author :
Publish date : 2025-11-10 22:22:00
Copyright for syndicated content belongs to the linked Source.
